| Symbol: |
LHX2
|
| Description: |
LIM homeobox 2 [Source:HGNC Symbol;Acc:6594]
|
| Location: |
Chr9:126763949-126795580[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:113
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| LHX2 |
NSC 673507 |
0.035 |
Down |
| LHX2 |
2-Naphthacenecarboxamide, N-[(6,7-dihydro-7-oxo-v-triazolo[4,5-d]pyrimidin-5-ylamino)methyl]-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo- |
0.001 |
Up |
| LHX2 |
NSC 676872 |
0.015 |
Down |
| LHX2 |
Phenothiazine, 2-azido-10-[4-(4-methyl-1-piperazinyl)butyl]-, difumarate |
0.001 |
Up |
| LHX2 |
10H-Phenothiazine, 10-(4-chlorobutyl)-1,3,4-trifluoro- 2-nitro- |
0.049 |
Down |
| LHX2 |
16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol |
0.041 |
Up |
| LHX2 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.034 |
Down |
| LHX2 |
1H-Indole, 3,3'-(2,5-piperazinediyl)bis(6-bromo-, (+-)-, dihydrobromide |
0.018 |
Down |
| LHX2 |
NSC 679509 |
0.04 |
Up |
| LHX2 |
NSC 680551 |
0.043 |
Down |
| LHX2 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4-ethyl- 11-[[[4-[[5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy- 3,5-dimethoxyphenyl)-6-oxofuro[3',4':6,7]naphtho[2,3-d]- 1,3-dioxol-9-yl]amino]phenyl]imino]methyl]-4-hydroxy-, hydrochloride, ste |
0.03 |
Down |
| LHX2 |
NSC 684438 |
0.013 |
Down |
| LHX2 |
3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- |
0.017 |
Up |
| LHX2 |
NSC 686659 |
0.036 |
Up |
| LHX2 |
NSC 688723 |
0.036 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:4
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:12
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:41
Total:3 Current:1
[First] [Prev]  Next Last 
|